Advertisements


We are Sorry, This Page doesn't Exist


Forty Seven Announces Potential Pricing for IPO

Clinical-stage immuno-oncology company Forty Seven intends to price more than 6 million shares so that the entire offering is valued up to more than $123 million......»»

Category: blogSource: 247wallstJun 18th, 2018

Ziopharm Oncology shares slide 7% premarket after FDA places clinical hold on cancer trial

Ziop.....»»

Category: topSource: marketwatchJun 18th, 2018

Quest Diagnostics (DGX) Presents At William Blair 2018 Growth Stock Conference - Slideshow

Quest Diagnostics (DGX) Presents At William Blair 2018 Growth Stock Conference - Slideshow.....»»

Category: topSource: seekingalphaJun 14th, 2018

PulteGroup Becomes #86 Most Shorted S&P 500 Component, Replacing Quest Diagnostics

Market News Video.....»»

Category: topSource: redinewsJun 12th, 2018

Aevi Genomics Medicine to increase sample size in Phase 2 Ascend clinical trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Surface Oncology initiated Phase I clinical trial of SRF373 / NZV930

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 12th, 2018

Analyst Favorites With Strong Buyback Activity: Ally Financial Ranks As a Top Pick

Market News Video.....»»

Category: topSource: redinewsJun 8th, 2018

Forty Seven Gears Up for IPO

Clinical-stage immuno-oncology company Forty Seven has amended its filing with the SEC regarding its initial public offering......»»

Category: blogSource: 247wallstJun 8th, 2018

William Blair upgrades Quest Diagnostics to Outperform on secular tailwinds

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 8th, 2018

Quest Diagnostics upgraded to Outperform from Market Perform at William Blair

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 8th, 2018

Incyte Moves Up In Market Cap Rank, Passing Quest Diagnostics

Market News Video.....»»

Category: topSource: redinewsJun 7th, 2018

KeyBanc Projects "Significant" Consolidation In Lab Testing Sector

Laboratory Corp. of America Holdings (NYSE: LH) and Quest Diagnostics Inc (NYSE: DGX) could benefit from a "significant wave" of consolidation in the lab testing and diagnostics sector, according to KeyBanc Capital Markets.  Latest Ratings for D.....»»

Category: blogSource: benzingaJun 7th, 2018

Wedbush’s Monday ASCO Roundup

The 54th annual meeting of the American Society of Clinical Oncology (ASCO) has just concluded and there were some significant moves we saw as a result......»»

Category: blogSource: 247wallstJun 5th, 2018

Loxo Oncology downgraded to Market Perform from Strong Buy at IFS Securities

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 5th, 2018

Jounce Therapeutics Sinks on ASCO Update

Jounce Therapeutics watched its shares drop sharply on Monday after the company presented preliminary data from its early stage cancer trial at the 2018 American Society of Clinical Oncology (ASCO)........»»

Category: blogSource: 247wallstJun 4th, 2018

5 Biotech Stocks Moving On ASCO Presentations

The American Society of Clinical Oncology.....»»

Category: blogSource: benzingaJun 4th, 2018

Celgene (CELG) Presents At 2018 American Society Of Clinical Oncology Annual Meeting - Slideshow

Celgene (CELG) Presents At 2018 American Society Of Clinical Oncology Annual Meeting - Slideshow.....»»

Category: topSource: seekingalphaJun 4th, 2018

Daiichi Sankyo (DSNKY) Presents At 2018 American Society Of Clinical Oncology Annual Meeting - Slideshow

Daiichi Sankyo (DSNKY) Presents At 2018 American Society Of Clinical Oncology Annual Meeting - Slideshow.....»»

Category: topSource: seekingalphaJun 4th, 2018

The Week Ahead In Biotech: ASCO Presentations Dominate The Headlines

A few FDA approvals and the impending 2018 American Society of Clinical Oncology annual meeting gave some impetus to the biotech space in the week ending June 1. read more.....»»

Category: blogSource: benzingaJun 3rd, 2018

Quest Diagnostics to participate in a conference call with JPMorgan

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 1st, 2018